Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Q3 FY25 earnings call: Revenue & Margins
Q3 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Mature hospitals show approximately 9% inpatient (IP) volume growth on a like-to-like basis. Rainbow Children's Medicare expects continued volume growth from both matured and new hospitals, with new hospitals growing faster and adding 12.5% capacity in FY '25-'26.
From Rainbow Childrens Medicare Ltd's Q3 FY25 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- Mature hospitals show approximately 9% inpatient (IP) volume growth on a like-to-like basis.
- New hospitals (operational less than 5 years) grow faster than mature hospitals, contributing to volume growth.
- Three new hospitals are planned in FY '25-'26, adding ~250 beds (12.5% capacity expansion), and ~130 beds planned for FY '26-'27.
- New hospitals are on expected occupancy and profitability trajectory, with breakeven expected within 12-18 months for recent openings.
- ARPP (Average Revenue Per Patient) growth is projected at 5%-8% due to pricing power and handling more complex cases as centers mature.
- Overall volume growth is supported by adding doctors, specialties in mature hospitals, and faster growth from newer hospitals.
2 more points from Rainbow Childrens Medicare Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Rainbow Childrens Medicare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY '25-26: Adding ~250 beds through asset-light leased assets, with capex of approximately INR 60-65 lakh per bed.
- FY '26-27: Plan to add ~130 beds, totaling roughly 380-400 beds over two years.
- Gurugram Project: INR 180-190 crores spent on land and approvals; an additional INR 400 crores expected as capex over FY '25-26 to FY '27-28, mostly post one year.
- Gurugram hospital to be a state-of-the-art, capital-intensive super-specialty facility with approx. INR 1.5 crores capex per bed.
- Total planned capex over next 2-3 years is around INR 550 crores.
2 more points from Rainbow Childrens Medicare Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Rainbow Childrens Medicare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Rainbow Childrens Medicare Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Rainbow Childrens Medicare Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹460 Cr, net profit ₹78 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Rainbow Childrens Medicare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Vimta Labs Ltd (Q3 FY25)
Q3 FY25 Revenue from Operations: ₹899 Mn . Key concall takeaways from Vimta Labs Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
- 3B Blackbio DX Ltd (Q3 FY25)
Consolidated Revenue from Operations Q3 FY 2024-25: ₹2,539.25 Lakh vs ₹1,766.89 Lakh in Q3 FY 2023-24 (↑ approx. Key concall takeaways from 3B Blackbio DX…
- Syngene International Ltd (Q3 FY25)
Q3 FY'25 showed an 11% revenue growth after two quarters of decline, indicating a return to growth momentum. Key concall takeaways from Syngene International…
- Vijaya Diagnostic Centre Ltd (Q3 FY25)
Wellness segment growth remains strong, contributing about 14% to the top line, with potential seasonal Q4 benefits. Key concall takeaways from Vijaya…
Arthneeti Pro · Annual
Rainbow Childrens Medicare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Rainbow Childrens Medicare Ltd Q3 FY25 results?
Mature hospitals show approximately 9% inpatient (IP) volume growth on a like-to-like basis. Rainbow Children's Medicare expects continued volume growth from both matured and new hospitals, with new hospitals growing faster and adding 12.5% capacity in FY '25-'26.
What is Rainbow Childrens Medicare Ltd share price analysis?
Rainbow Childrens Medicare Ltd currently shows a neutral. The stock trades at a P/E of 50.8 with a market cap of ₹14,557 Cr. Investors should review the full earnings analysis for detailed insights.
Is Rainbow Childrens Medicare Ltd planning capital expenditure?
FY '25-26: Adding ~250 beds through asset-light leased assets, with capex of approximately INR 60-65 lakh per bed. - FY '26-27: Plan to add ~130 beds, totaling roughly 380-400 beds over two years. - Gurugram Project: INR 180-190 crores spent on land and approvals; an additional INR 400 crores expected as capex over FY '25-26 to FY '27-28, mostly post one year. - Gurugram hospital to be a state-of-the-art, capital-intensive super-specialty facility with approx.
Keep Rainbow Childrens Medicare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.